The SECTA infusion pump is currently in development for use in intravenous drips, with a trial being conducted at St Bartholomew’s Hospital in London, after attracting strong interest at the recent Medical Device Technology Exhibition.

Ian Cameron, London-focused Capital’s investment director believes ‘PDD Innovations has created a truly innovative, disruptive pump technology that has huge potential for applications across a range of sectors, where it could generate considerable cost-savings. We are pleased to provide the funding PDD Innovations needs to take the SECTA product to the next stage.